Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

vandetanib

EU orphan designation number: EU/3/05/344
Active ingredient: vandetanib
Indication: Treatment of medullary thyroid carcinoma
Sponsor: AstraZeneca UK Limited
Alderley Park, Macclesfield, Cheshire, SK10 4TG United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/01/2006 Orphan Designation EMEA/OD/089/05 (2006)209 of 24/01/2006
26/08/2010 Removal of orphan designation from Community Register